Literature DB >> 26309867

Nd: Yag laser iridotomy in Shaffer-Etienne grade 1 and 2: angle widening in our case studies.

Sandra Cinzia Carlesimo1, Luigi Di Santo2, Pietro Bruni1, Aloisa Librando1, Antonietta Pompea Falace1, Andrea Barbato1.   

Abstract

AIM: To obtain widening of a potentially occludable angle, in according to Kanski's indications, through preventive Nd:Yag laser iridotomy. The observational study was performed by using gonioscopy for the selection and follow-up of 1165 treated eyes and exploiting Shaffer-Etienne gonioscopic classification as a quality/quantity test of the angle recession.
METHODS: Between September 2000 and July 2012, 586 patients were selected at the Outpatients' Ophthalmological Clinic of the Policlinico Umberto I of Rome in order to undergo Nd: Yag laser iridotomy. A Goldmann type contact lens, Q-switched mode, 2-3 defocus, and 7-9 mJ intensity with 2-3 impulse discharges were used for surgery.
RESULTS: From as early as the first week, a whole 360° angle widening were evident in the patients, thus showing the success of Nd:Yag laser iridotomy in solving relative pupil block. The angle remained narrow by 270° in 14 eyes only, despite repetitions of further treatment with laser iridotomy in a different part of the iris, twice in 10 eyes and three times in 4 eyes.
CONCLUSION: Nd:Yag laser iridotomy revealed itself as being a safe and effective treatment in widening those critical Shaffer-Etienne grade 1 and 2 potentially occludable angles.

Entities:  

Keywords:  Nd:Yag laser; glaucoma; gonioscopy; intraocular pressure; iridotomy; narrow angle

Year:  2015        PMID: 26309867      PMCID: PMC4539651          DOI: 10.3980/j.issn.2222-3959.2015.04.12

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  37 in total

1.  Primary angle-closure glaucoma is a multifactorial disease.

Authors:  Ravi Thomas; Mark J Walland
Journal:  Clin Exp Ophthalmol       Date:  2011 Sep-Oct       Impact factor: 4.207

Review 2.  The prevalence of primary angle closure glaucoma in European derived populations: a systematic review.

Authors:  Alexander C Day; Gianluca Baio; Gus Gazzard; Catey Bunce; Augusto Azuara-Blanco; Beatriz Munoz; David S Friedman; Paul J Foster
Journal:  Br J Ophthalmol       Date:  2012-05-31       Impact factor: 4.638

3.  New considerations on pupillary block mechanism.

Authors:  Sebastião Cronemberger; Nassim Calixto; André Oliveira de Andrade; Rafael Vidal Mérula
Journal:  Arq Bras Oftalmol       Date:  2010 Jan-Feb       Impact factor: 0.872

4.  A prospective ultrasound biomicroscopy evaluation of changes in anterior segment morphology following laser iridotomy in European eyes.

Authors:  K Mansouri; N D Burgener; M Bagnoud; T Shaarawy
Journal:  Eye (Lond)       Date:  2009-01-09       Impact factor: 3.775

5.  Laser iridotomy.

Authors:  P Richardson; R L Cooper
Journal:  Aust N Z J Ophthalmol       Date:  1987-05

Review 6.  Angle closure glaucoma: a mechanistic review.

Authors:  Monisha E Nongpiur; Judy Y F Ku; Tin Aung
Journal:  Curr Opin Ophthalmol       Date:  2011-03       Impact factor: 3.761

7.  Corneal endothelial damage after neodymium:YAG laser iridotomy.

Authors:  S C Wu; S Jeng; S C Huang; S M Lin
Journal:  Ophthalmic Surg Lasers       Date:  2000 Sep-Oct

8.  Laser peripheral iridotomy in primary angle-closure suspects: biometric and gonioscopic outcomes: the Liwan Eye Study.

Authors:  Mingguang He; David S Friedman; Jian Ge; Wenyong Huang; Chenjin Jin; Pak Sang Lee; Peng T Khaw; Paul J Foster
Journal:  Ophthalmology       Date:  2006-11-21       Impact factor: 12.079

Review 9.  Genetic susceptibility to primary angle closure glaucoma (PACG).

Authors:  Barkur S Shastry
Journal:  Discov Med       Date:  2013-01       Impact factor: 2.970

10.  Cataract surgery complications: an in vitro model of toxic effects of ropivacaine and lidocaine.

Authors:  Nicola Pescosolido; Gianfranco Scarsella; Marco Tafani; Marcella Nebbioso
Journal:  Drugs R D       Date:  2011-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.